These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9564034)

  • 1. The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis.
    Brown DR; Thomas CA; Deb SP
    EMBO J; 1998 May; 17(9):2513-25. PubMed ID: 9564034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function and dysfunction of the human oncoprotein MDM2.
    Deb SP
    Front Biosci; 2002 Jan; 7():d235-43. PubMed ID: 11779693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants.
    Brown DR; Deb D; Frum R; Hickes L; Munoz R; Deb S; Deb SP
    Int J Oncol; 2001 Mar; 18(3):449-59. PubMed ID: 11179471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth arrest function of the human oncoprotein mouse double minute-2 is disabled by downstream mutation in cancer cells.
    Zhou R; Frum R; Deb S; Deb SP
    Cancer Res; 2005 Mar; 65(5):1839-48. PubMed ID: 15753382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulatory functions of the human oncoprotein MDM2.
    Deb SP
    Mol Cancer Res; 2003 Dec; 1(14):1009-16. PubMed ID: 14707284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts.
    Kurokawa K; Tanaka T; Kato J
    Oncogene; 1999 Apr; 18(17):2718-27. PubMed ID: 10348346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of MDM2-mediated growth arrest.
    Frum R; Deb SP
    Methods Mol Biol; 2003; 234():257-67. PubMed ID: 12824538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest.
    Dubs-Poterszman MC; Tocque B; Wasylyk B
    Oncogene; 1995 Dec; 11(11):2445-9. PubMed ID: 8570197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mdm2, p53 and the cell cycle: when well enough is best left alone].
    Maréchal V
    Pathol Biol (Paris); 1997 Dec; 45(10):824-32. PubMed ID: 9769946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.
    Oliner JD; Pietenpol JA; Thiagalingam S; Gyuris J; Kinzler KW; Vogelstein B
    Nature; 1993 Apr; 362(6423):857-60. PubMed ID: 8479525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B; Pennell N; Berinstein NL
    Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2.
    Boyd MT; Vlatkovic N; Haines DS
    J Biol Chem; 2000 Oct; 275(41):31883-90. PubMed ID: 10906133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.
    Jones SN; Roe AE; Donehower LA; Bradley A
    Nature; 1995 Nov; 378(6553):206-8. PubMed ID: 7477327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative translated MDMX(p60) isoform regulates MDM2 activity.
    Tournillon AS; López I; Malbert-Colas L; Naski N; Olivares-Illana V; Fåhraeus R
    Cell Cycle; 2015; 14(3):449-58. PubMed ID: 25659040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation.
    Williams AC; Miller JC; Collard TJ; Bracey TS; Cosulich S; Paraskeva C
    Oncogene; 1995 Jul; 11(1):141-9. PubMed ID: 7624121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
    Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
    Olson DC; Marechal V; Momand J; Chen J; Romocki C; Levine AJ
    Oncogene; 1993 Sep; 8(9):2353-60. PubMed ID: 7689721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells.
    Teoh G; Urashima M; Ogata A; Chauhan D; DeCaprio JA; Treon SP; Schlossman RL; Anderson KC
    Blood; 1997 Sep; 90(5):1982-92. PubMed ID: 9292533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nucleolar protein, PAPA-1, induces growth arrest as a result of cell cycle arrest at the G1 phase.
    Kuroda TS; Maita H; Tabata T; Taira T; Kitaura H; Ariga H; Iguchi-Ariga SM
    Gene; 2004 Sep; 340(1):83-98. PubMed ID: 15556297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between the retinoblastoma protein and the oncoprotein MDM2.
    Xiao ZX; Chen J; Levine AJ; Modjtahedi N; Xing J; Sellers WR; Livingston DM
    Nature; 1995 Jun; 375(6533):694-8. PubMed ID: 7791904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.